Third quarter results 2021 for Medistim ASA

Sales revenues for the quarter ended at MNOK 102.1 (MNOK 83.4), an increase of 22.5%. Sales as of September ended at MNOK 309.2 (MNOK 268.9) a 15.0% increase.

Sales in the USA increased by 11.9 % in NOK. Currency neutral growth was 24.9%.

Currency neutral sales of own products increased by 33% for the quarter.

Total revenues YTD September include the Paycheck Protection Program income and reach MNOK 314.5.

Operating result (EBIT) for the quarter ended at MNOK 25.1 (MNOK 20.8) a 20.3% increase. EBIT year to date September ended at MNOK 96.8 (MNOK 73.3), a 32.0% increase. This is the best operating result YTD September ever.

Cash flow from operations YTD was a solid MNOK 81.2. Cash by the end of the quarter was MNOK 89.7.